γδ T CELLS MEDIATE IMMUNOTHERAPY RESPONSE IN HLA CLASS I-DEFICIENT CANCERS

被引：0
|
作者：
不详
机构：
来源：
CANCER DISCOVERY | 2023年 / 13卷 / 03期
关键词：
D O I：
10.1158/2159-8290.CD-RW2023-012
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
γδ T cells contribute to the efficacy of immunotherapy in the absence of antigen presentation. ©2023 American Association for Cancer Research.
引用
收藏
页码：528 / 528
页数：1
相关论文
共 50 条
  • [41] αβTCR+ cells are a minimal fraction of peripheral CD8+ pool in MHC class I-deficient mice
    Nesic, D
    Santori, FR
    Vukmanovic, S
    JOURNAL OF IMMUNOLOGY, 2000, 165 (04): : 1896 - 1901
  • [42] MHC class I-deficient metastatic tumor variants immunoselected by T lymphocytes originate from the coordinated downregulation of APM components
    Garcia-Lora, A
    Martinez, M
    Algarra, I
    Gaforio, LJ
    Garrido, F
    INTERNATIONAL JOURNAL OF CANCER, 2003, 106 (04) : 521 - 527
  • [43] TEIPP antigens for T-cell based immunotherapy of immune-edited HLA class Ilow cancers
    Marijt, Koen A.
    Doorduijn, Ellen M.
    van Hall, Thorbald
    MOLECULAR IMMUNOLOGY, 2019, 113 : 43 - 49
  • [44] Markedly decreased expression of TAP1 and LMP2 genes in HLA class I-deficient human tumor cell lines
    Singal, DP
    Ye, M
    Ni, J
    Snider, DP
    IMMUNOLOGY LETTERS, 1996, 50 (03) : 149 - 154
  • [45] Impact of HLA class I alterations in cancer patients undergoing T cell specific immunotherapy
    Méndez, R
    Ruiz-Cabello, F
    Jiménez, P
    Cabrera, T
    López-Nevot, MA
    Knuth, A
    Jager, E
    Traversari, C
    Schadendorff, D
    Boon, T
    Garrido, F
    TISSUE ANTIGENS, 2002, 59 : 32 - 32
  • [46] Altered expression of Ly49 inhibitory receptors on natural killer cells from MHC class I-deficient mice
    Salcedo, M
    Diehl, AD
    OlssonAlheim, MY
    Sundback, J
    VanKaer, L
    Karre, K
    Ljunggren, HG
    JOURNAL OF IMMUNOLOGY, 1997, 158 (07): : 3174 - 3180
  • [47] Article Long-lasting mRNA-encoded interleukin-2 restores CD8+T cell neoantigen immunity in MHC class I-deficient cancers
    Beck, Jan D.
    Diken, Mustafa
    Suchan, Martin
    Streuber, Michael
    Diken, Elif
    Kolb, Laura
    Allnoch, Lisa
    Vascotto, Fulvia
    Peters, Daniel
    Beissert, Tim
    Akilli-Oeztuerk, Oezlem
    Tuereci, Oezlem
    Kreiter, Sebastian
    Vormehr, Mathias
    Sahin, Ugur
    CANCER CELL, 2024, 42 (04) : 568 - 582.e11
  • [48] A SCIENTIFIC MYTH: THERE IS MORE HLA CLASS I ON B CELLS THAN ON T CELLS
    Sequeira, Flavia
    Tyan, Dolly
    Chen, Ge
    HUMAN IMMUNOLOGY, 2015, 76 (04) : 225 - 225
  • [49] DEVELOPMENT AND AG SPECIFICITY OF CD8+ CYTOTOXIC T-LYMPHOCYTES IN BETA-2-MICROGLOBULIN NEGATIVE, MHC CLASS I-DEFICIENT MICE IN RESPONSE TO IMMUNIZATION WITH TUMOR-CELLS
    APASOV, SG
    SITKOVSKY, MV
    FASEB JOURNAL, 1994, 8 (05): : A1006 - A1006
  • [50] "Hard" and "soft" lesions underlying the HLA Class I alterations in cancer cells: implications for immunotherapy
    Garrido, Federico
    Cabrera, Teresa
    Aptsiauri, Natalia
    INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (02) : 249 - 256
12345